Sponsorship Opportunities for DPL XXXVII!

The American Society for Pharmacy Law (ASPL) is an organization of attorneys, pharmacists, pharmacist-attorneys and students of pharmacy or law who are interested in the law as it applies to pharmacy, pharmacists, wholesalers, manufacturers, state and federal government and other interested parties.

ASPL is a non-profit which encourages diversity & inclusion with the Society, regardless of differing backgrounds, perspectives, experiences, orientations, origins, and practice settings. The Society embraces participation and diversity as it leads to advancing our purpose: 

  • Furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues;
  • Communicating accurate legal educational information; and
  • Providing educational opportunities for pharmacists, attorneys, and others who are interested in pharmacy law

Latest News

FDA Issues Warning to Telehealth Companies Compounding

In the warning, FDA reminded telehealth companies not to market compounded GLP-1 drugs to consumers with false or misleading claims, including:

  • Using branding on their website that falsely or misleadingly implies the telehealth company is the compounder.
  • Describing a compounded drug as a generic version of an FDA-approved drug or the same as a drug approved by FDA.
  • Claiming a compounded drug has been FDA-approved or has otherwise been evaluated for safety and effectiveness when they are not.
  • Describing a compounded drug as clinically proven to produce the same result as the FDA-approved drug.
  • Claiming a compounded drug is sourced from an FDA-approved or FDA-licensed pharmacy or outsourcing facility.

[FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs. FDA 15 June 2026.]